Top

Published in:

Open Access 01-12-2015 | Study protocol

The Link4Health study to evaluate the effectiveness of a combination intervention strategy for linkage to and retention in HIV care in Swaziland: protocol for a cluster randomized trial

Authors: Margaret L. McNairy, Averie B. Gachuhi, Matthew R. Lamb, Harriet Nuwagaba-Biribonwoha, Sean Burke, Peter Ehrenkranz, Sikhathele Mazibuko, Ruben Sahabo, Neena M. Philip, Velephi Okello, Wafaa M. El-Sadr

Published in: Implementation Science | Issue 1/2015

Abstract

Background

Gaps in the HIV care continuum contribute to suboptimal individual health outcomes and increased risk of HIV transmission at the population level. Implementation science studies are needed to evaluate clinic-based interventions aimed at improving retention of patients across the continuum.

Methods/design

Link4Health uses an unblended cluster site-randomized design to evaluate the effectiveness of a combination intervention strategy (CIS) as compared to standard of care on linkage to and retention in care among HIV-diagnosed adults in Swaziland. The CIS intervention targets a multiplicity of structural, behavioral, and biomedical barriers through five interventions: (1) point-of-care CD4 testing at time of HIV testing, (2) accelerated antiretroviral therapy (ART) initiation for eligible patients, (3) mobile phone appointment reminders, (4) care and prevention packages, and (5) non-cash financial incentives for linkage and retention. The unit of randomization is a network of HIV clinics inclusive of a secondary facility coupled with an affiliated primary facility. Ten study units were randomized based on implementing partner, geographic location, and historic volume of HIV patients. Target enrollment was 2200 individuals, each to be followed for 12 months. Eligibility criteria includes HIV-positive test, age >18 years, willing to receive HIV care at a clinic in the study unit and consent to study procedures. Exclusion criteria included previous HIV care in the past 6 months, planning to leave the community, and current pregnancy.

The primary study outcome is linkage within 1 month and retention at 12 months after testing HIV positive. Secondary outcomes include viral load suppression at 12 months, time to ART eligibility and initiation, participant acceptability, and cost-effectiveness. The trial status is that study enrollment is complete and follow-up procedures are ongoing.

Discussion

Link4Health evaluates a novel and pragmatic combination intervention strategy to improve linkage to and retention in care among adults with HIV in Swaziland. If the strategy is found to be effective, this study has the potential to inform HIV service delivery in resource-limited settings.

Trial registration

Clinicaltrials.gov NCT01904994

Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52(6):793–800. doi:10.1093/cid/ciq243.PubMedPubMedCentral

Cohen SM, Van Handel MM, Branson BM, Blair JM, Hall HI, Hu X, et al. Vital signs: HIV prevention through care and treatment—United States. MMWR Morb Mortal Wkly Rep. 2011;60:1618–23.

Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505. doi:10.1056/NEJMoa1105243.PubMedPubMedCentral

McNairy ML, El-Sadr WM. The HIV care continuum: no partial credit given. AIDS. 2012;26(14):1735–8. doi:10.1097/QAD.0b013e328355d67b.PubMed

Barker PM, Mphatswe W, Rollins N. Antiretroviral drugs in the cupboard are not enough: the impact of health systems’ performance on mother-to-child transmission of HIV. J Acquir Immune Defic Syndr. 2011;56(2):e45–8. doi:10.1097/QAI.0b013e3181fdbf20.PubMed

Makadzange AT, Ndhlovu CE, Takarinda K, Reid M, Kurangwa M, Gona P, et al. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-Saharan Africa. Clin Infect Dis. 2010;50(11):1532–8. doi:10.1086/652652.PubMed

Lawn SD, Kranzer K, Wood R. Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings. Clin Chest Med. 2009;30(4):685–99. doi:10.1016/j.ccm.2009.08.010. viii.PubMedPubMedCentral

Fisher JD, Smith L. Secondary prevention of HIV infection: the current state of prevention for positives. Curr Opin HIV AIDS. 2009;4(4):279–87. doi:10.1097/COH.0b013e32832c7ce5.PubMedPubMedCentral

Lawn SD, Wood R. How can earlier entry of patients into antiretroviral programs in low-income countries be promoted? Clin Infect Dis. 2006;42(3):431–2.PubMed

10.

Bisson GP, Gaolathe T, Gross R, Rollins C, Bellamy S, Mogoosi M, et al. Overestimates of survival after HAART: implications for global scale-up efforts. PLoS One. 2008;3(3), e1725.PubMedPubMedCentral

11.

Brinkhof MW, Pujades-Rodriguez M, Egger M. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One. 2009;4(6): e5790.PubMedPubMedCentral

12.

Dalal RP, Macphail C, Mghayi M, Wing J, Feldman C, Chersich MF, Venter WD, et al. Characteristics and outcomes of adult patients lost to follow-up at an antiretroviral treatment clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2008;47(1):101–7.

13.

Krebs DW, Chi BH, Mulenga Y, Morris M, Cantrell RA, Mulenga L, et al.. Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka. Zambia AIDS Care. 2008;20(3):311–7.

14.

Maskew M, MacPhail P, Rubel D. Lost to follow up: contributing factors and challenges in South African patients on antiretroviral therapy. S Afr Med J. 2007;97(9):853–7.

15.

McGrath N, Glynn JR, Saul J, Kranzer K, Jahn A, Mwaungulu F, et al. What happens to ART-eligible patients who do not start ART? Dropout between screening and ART initiation: a cohort study in Karonga, Malawi. BMC Public Health. 2010;10:601.PubMedPubMedCentral

16.

Yu JK, Chen SC, Wang KY, Chang CS, Makombe SD, Schouten EJ, Harries AD. True outcomes for patients on antiretroviral therapy who are “lost to follow-up” in Malawi. Bull World Health Organ. 2007;85(7):550–4.

17.

Fairall LR, Bachmann MO, Louwagie GM, van Vuuren C, Chikobvu P, Steyn D, et al. Effectiveness of antiretroviral treatment in a South African program: a cohort study. Arch Intern Med. 2008;168(1):86–93.PubMed

18.

Hoffman S, Charalambous S, Churchyard G, Martinson N, Chaisson R. Delayed ART initiation and risk of death, Abstract 560. Boston, MA: Conference of Retroviruses and Opportunistic Infections (CROI); 2011.

19.

Elul B, Lahuerta M, Abacassamo F, Lamb MR, Ahoua L, McNairy ML, Tomo M, et al. A combination strategy for enhancing linkage to and retention in HIV care among adults newly diagnosed with HIV in Mozambique: study protocol for a site-randomized implementation science study. BMC Infect Dis. 2014;14:549.PubMedPubMedCentral

20.

Amuron B, Namara G, Birungi J, Nabiryo C, Levin J, Grosskurth H, et al. Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health. 2009;9:290.PubMedPubMedCentral

21.

Byakika-Tusiime J, Crane J, Oyugi JH, Ragland K, Kawuma A, Musoke P, Bangsberg D. Longitudinal antiretroviral adherence in HIV+ Ugandan parents and their children initiating HAART in the MTCT-Plus family treatment model: role of depression in declining adherence over time. AIDS Behav. 2009;13 Suppl 1:82–91.PubMed

22.

Dahab M, Charalambous S, Hamilton R, Fielding K, Kielmann K, Churchyard GJ, Grant AD. “That is why I stopped the ART”: patients’ & providers’ perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme. BMC Public Health. 2008;8:63.PubMedPubMedCentral

23.

Geng EH, Bangsberg DR, Musinguzi N, Emenyonu N, Bwana MB, Yiannoutsos CT, et al. Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach. J Acquir Immune Defic Syndr. 2010;53(3):405–11.PubMedPubMedCentral

24.

Kaplan R, Orrell C, Zwane E, Bekker LG, Wood R. Loss to follow-up and mortality among pregnant women referred to a community clinic for antiretroviral treatment. AIDS. 2008;22(13):1679–81.PubMedPubMedCentral

25.

Kip E, Ehlers VJ, van der Wal DM. Patients’ adherence to anti-retroviral therapy in Botswana. J Nurs Scholarsh. 2009;41(2):149–57.

26.

Rabkin, M. High patient retention rates in a multinational HIV/AIDS treatment program: the Columbia University mother-to-child-plus experience. San Francisco, CA: Conference on Retroviruses and Opportunistic Infections (CROI); 2010.

27.

Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, Wu P, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med. 2006;3(11): e438.PubMedPubMedCentral

28.

Ochieng-Ooko V, Ochieng D, Sidle JE, Holdsworth M, Wools-Kaloustian K, Siika AM, et al. Influence of gender on loss to follow-up in a large HIV treatment programme in western Kenya. Bull World Health Organ. 2010;88(9):681–8.PubMedPubMedCentral

29.

Tessema B, Biadglegne F, Mulu A, Getachew A, Emmrich F, Sack U. Magnitude and determinants of nonadherence and nonreadiness to highly active antiretroviral therapy among people living with HIV/AIDS in Northwest Ethiopia: a cross-sectional study. AIDS Res Ther. 2010;7:2.PubMedPubMedCentral

30.

Wringe A, Roura M, Urassa M, Busza J, Athanas V, Zaba B. Doubts, denial and divine intervention: understanding delayed attendance and poor retention rates at a HIV treatment programme in rural Tanzania. AIDS care. 2009;21(5):632–7.PubMed

31.

El-Sadr WM, Philip NM, Justman J. Letting HIV transform academia—embracing implementation science. N Engl J Med. 2014;370(18):1679–81. doi:10.1056/NEJMp1314777.PubMed

32.

Padian NS, Holmes CB, McCoy SI, Lyerla R, Bouey PD, Goosby EP. Implementation science for the US President’s Emergency Plan for AIDS Relief (PEPFAR). J Acquir Immune Defic Syndr. 2011;56(3):199–203. doi:10.1097/QAI.0b013e31820bb448.PubMed

33.

Centers for Disease Control and Prevention. CDC in Swaziland Factsheet. http://www.cdc.gov/globalhealth/countries/swaziland/pdf/swaziland_2013.pdf. Accessed June 1 2015.

34.

Bicego GT, Nkambule R, Peterson I, Reed J, Donnell D, Ginindza H, et al. Recent patterns in population-based HIV prevalence in Swaziland. PLoS One. 2013;8(10), e77101. doi:10.1371/journal.pone.0077101.PubMedPubMedCentral

35.

Ministry of Health Kingdom of Swaziland. Swaziland HIV Incidence Measurement Survey (SHMIS). Final Findings Report. November 2012. Mbabane Swaziland: Swaziland Ministry of Health, ICAP at Columbia University, PEPFAR, SCHARP; 2012.

36.

Ministry of Health Kingdom of Swaziland. Annual HIV Programs Report, 2013. Mbabane, Swaziland: Swaziland Ministry of Health; 2013.

37.

Auld AF, Agolory SG, Shiraishi RW, Wabwire-Mangen F, Kwesigabo G, Mulenga M, et al. Antiretroviral therapy enrollment characteristics and outcomes among HIV-infected adolescents and young adults compared with older adults—seven African countries, 2004–2013. MMWR Morb Mortal Wkly Rep. 2014;63(47):1097–103.PubMed

38.

Auld AF, Kamiru H, Azih C, Baughman AL, Nuwagaba-Biribonwoha H, Ehrenkranz P, et al. Implementation and operational research: evaluation of Swaziland’s hub-and-spoke model for decentralizing access to antiretroviral therapy services. J Acquir Immune Defic Syndr. 2015;69(1):e1–e12. doi:10.1097/QAI.0000000000000547.PubMed

39.

Larson BAB, McNamara L, Long L, Rosen S, Sanne I, Fox M. A lost opportunity: most VCT patients who test positive for HIV in a large South African clinic do not initiate HIV care, Abstract 826. San Francisco, CA: CROI; 2010.

40.

Jani IV, Sitoe NE, Chongo P, Lehe J, Rocha B, Quevedo J, Peter T. Point of care CD4 improves patient retention and time-to-initiation of ART in Mozambique, Abstract FRLBE101. Vienna, Austria: AIDS; 2010.

41.

Faal M, Naidoo N, Makgamatha L, Venter F, Osih R. Effect of an immediate CD4 result during VCT on patient retention in ART, Abstract TUPE011. Vienna, Austria: AIDS; 2010.

42.

Larson BA, Schnippel K, Ndibongo B, Xulu T, Brennan A, Long L, et al. Rapid point-of-care CD4 testing at mobile HIV testing sites to increase linkage to care: an evaluation of a pilot program in South Africa. J Acquir Immune Defic Syndr. 2012;61(2):e13–7.PubMedPubMedCentral

43.

Bassett IV, Regan S, Chetty S, Giddy J, Uhler LM, Holst H, et al. Who starts antiretroviral therapy in Durban, South Africa?… not everyone who should. AIDS. 2010;24 Suppl 1:S37–44. doi:10.1097/01.aids.0000366081.91192.1c.PubMedPubMedCentral

44.

Lawn SD, Harries AD, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2008;22(15):1897–908. doi:10.1097/QAD.0b013e32830007cd.PubMed

45.

Ingle SM, May M, Uebel K, Timmerman V, Kotze E, Bachmann M, et al. Outcomes in patients waiting for antiretroviral treatment in the Free State Province, South Africa: prospective linkage study. AIDS. 2010;24(17):2717–25. doi:10.1097/QAD.0b013e32833fb71f.PubMedPubMedCentral

46.

Chang LW, Kagaayi J, Nakigozi G, Packer AH, Serwadda D, Quinn TC, et al. Responding to the human resource crisis: peer health workers, mobile phones, and HIV care in Rakai, Uganda. AIDS Patient Care STDS. 2008;22(3):173–4.PubMedPubMedCentral

47.

Downer SR, Meara JG, Da Costa AC, Sethuraman K. SMS text messaging improves outpatient attendance. Aust Health Rev. 2006;30(3):389–96.PubMed

48.

Fjeldsoe BS, Marshall AL, Miller YD. Behavior change interventions delivered by mobile telephone short-message service. Am J Prev Med. 2009;36(2):165–73.PubMed

49.

Haberer JE, Kiwanuka J, Nansera D, Wilson IB, Bangsberg DR. Challenges in using mobile phones for collection of antiretroviral therapy adherence data in a resource-limited setting. AIDS Behav. 2010;14(6):1294–301.PubMedPubMedCentral

50.

Lester RT, Ritvo P, Mills EJ, Kariri A, Karanja S, Chung MH, et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet. 2010;376(9755):1838–45.PubMed

51.

Liew SM, Tong SF, Lee VK, Ng CJ, Leong KC, Teng CL. Text messaging reminders to reduce non-attendance in chronic disease follow-up: a clinical trial. Br J Gen Pract. 2009;59(569):916–20.PubMedPubMedCentral

52.

Mukund Bahadur KC, Murray PJ. Cell phone short messaging service (SMS) for HIV/AIDS in South Africa: a literature review. Stud Health Technol Inform. 2010;160(Pt 1):530–5.PubMed

53.

Pop-Eleches C, Thirumurthy H, Habyarimana JP, Zivin JG, Goldstein MP, de Walque D, et al. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS. 2011;25(6):825–34.PubMedPubMedCentral

54.

Shet A. India calling: harnessing the promise of mobile phones for HIV healthcare. Trop Med Int Health. 2011;16(2):214–6.PubMed

55.

Colindres P, Mermin J, Ezati E, Kambabazi S, Buyungo P, Sekabembe L, et al. Utilization of a basic care and prevention package by HIV-infected persons in Uganda. AIDS Care. 2008;20(2):139–45. AIDS Care. Feb 2008;20(2):139–45.PubMed

56.

Houts PS, Doak CC, Doak LG, Loscalzo MJ. The role of pictures in improving health communication: a review of research on attention, comprehension, recall, and adherence. Patient Educ Couns. 2006;61(2):173–90.PubMed

57.

Kripalani S, LeFevre F, Phillips CO, Williams MV, Basaviah P, Baker DW. Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care. JAMA. 2007;297(8):831–41.PubMed

58.

Ngoh LN, Shepherd MD. Design, development, and evaluation of visual aids for communicating prescription drug instructions to nonliterate patients in rural Cameroon. Patient Educ Couns. 1997;30(3):257–70.PubMed

59.

Kohler PK, Chung MH, McGrath CJ, Benki-Nugent SF, Thiga JW, John-Stewart GC. Free CTX substantially improves retention among ART-ineligible clients in a Kenyan HIV treatment program. Boston, MA: Conference on Retroviruses and Opportunistic Infections (CROI); 2011.

60.

Volpp KG, John LK, Troxel AB, Norton L, Fassbender J, Loewenstein G. Financial incentive-based approaches for weight loss: a randomized trial. JAMA. 2008;300(22):2631–7. doi:10.1001/jama.2008.804.PubMedPubMedCentral

61.

Volpp KG, Loewenstein G, Troxel AB, Doshi J, Price M, Laskin M, et al. A test of financial incentives to improve warfarin adherence. BMC Health Serv Res. 2008;8:272. doi:10.1186/1472-6963-8-272.PubMedPubMedCentral

62.

Volpp KG, Troxel AB, Pauly MV, Glick HA, Puig A, Asch DA, et al. A randomized, controlled trial of financial incentives for smoking cessation. N Engl J Med. 2009;360(7):699–709. doi:10.1056/NEJMsa0806819.PubMed

63.

Charness G, Gneezy U. Incentives to exercise. Econometrica. 2009;77(3):909–31.

64.

Marcus AC, Kaplan CP, Crane LA, Berek JS, Bernstein G, Gunning JE, et al. Reducing loss-to-follow-up among women with abnormal Pap smears. Results from a randomized trial testing an intensive follow-up protocol and economic incentives. Med Care. 1998;36(3):397–410.PubMed

65.

Malotte CK, Rhodes F, Mais KE. Tuberculosis screening and compliance with return for skin test reading among active drug users. Am J Public Health. 1998;88(5):792–6.PubMedPubMedCentral

66.

Giuffrida A, Torgerson DJ. Should we pay the patient? Review of financial incentives to enhance patient compliance. BMJ. 1997;315(7110):703–7.PubMedPubMedCentral

Title: The Link4Health study to evaluate the effectiveness of a combination intervention strategy for linkage to and retention in HIV care in Swaziland: protocol for a cluster randomized trial
Authors: Margaret L. McNairy
Averie B. Gachuhi
Matthew R. Lamb
Harriet Nuwagaba-Biribonwoha
Sean Burke
Peter Ehrenkranz
Sikhathele Mazibuko
Ruben Sahabo
Neena M. Philip
Velephi Okello
Wafaa M. El-Sadr
Publication date: 01-12-2015
Publisher: BioMed Central
Published in: Implementation Science / Issue 1/2015
Electronic ISSN: 1748-5908
DOI: https://doi.org/10.1186/s13012-015-0291-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The Link4Health study to evaluate the effectiveness of a combination intervention strategy for linkage to and retention in HIV care in Swaziland: protocol for a cluster randomized trial

Abstract

Background

Methods/design

Discussion

Trial registration

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods/design

Discussion

Trial registration

Please log in to get access to this content

Other articles of this Issue 1/2015

A cluster randomised controlled trial evaluating the effectiveness of eHealth-supported patient recruitment in primary care research: the TRANSFoRm study protocol

Development of a behaviour change intervention to increase upper limb exercise in stroke rehabilitation

A survey of knowledge-to-action pathways of aging policies and programs in the Arab region: the role of institutional arrangements

“Entrenched practices and other biases”: unpacking the historical, economic, professional, and social resistance to de-implementation

Gaps between research and public health priorities in low income countries: evidence from a systematic literature review focused on Cambodia

The evaluation of a tailored intervention to improve the management of suspected viral encephalitis: protocol for a cluster randomised controlled trial